Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/22/1994 | WO1994029330A1 Myeloid cell leukemia associated gene mcl-1 |
12/22/1994 | WO1994028938A1 Adenovirus vectors for gene therapy sponsorship |
12/22/1994 | WO1994028931A1 Methods for treating inflammatory disorders |
12/22/1994 | WO1994028928A1 Novel attenuated pseudomonas aeruginosa strains |
12/22/1994 | WO1994028925A1 Vaccine containing a serine protease |
12/22/1994 | WO1994028920A1 Synthetic peptide inhibitors of hiv transmission |
12/22/1994 | WO1994028915A1 Hiv retrovirus infection inhibitor capable of interacting with cd26 receptor |
12/22/1994 | WO1994028914A1 Assay and reagents for identifying anti-proliferative agents |
12/22/1994 | WO1994028897A2 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
12/22/1994 | WO1994028724A1 Bacillus thuringiensis strains capable of producing large amonts of insecticidal crystal proteins |
12/22/1994 | WO1994028721A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
12/22/1994 | WO1994028720A1 Oligomers for modulating ras oncogene |
12/22/1994 | WO1994028713A1 Olpidium zoospores as vectors of recombinant dna to plants |
12/22/1994 | WO1994026889A3 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
12/22/1994 | WO1994025617A3 Monoclonal antibodies against ck-mb |
12/22/1994 | WO1994025606A3 Recombinant alanine racemase and gapdh from tolypocladium |
12/22/1994 | WO1994025596A3 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
12/22/1994 | WO1994025593A3 Method for obtaining male-sterile plants |
12/22/1994 | WO1994025590A3 Trichohyalin and transglutaminase-3 and methods of using same |
12/22/1994 | WO1994025588A3 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β) |
12/22/1994 | WO1994025477A3 Novel peptide nucleic acids |
12/22/1994 | WO1994021805A3 Method of controlling insects in plants |
12/22/1994 | WO1994020628A3 Improved feedcrops enriched in sulfur amino acids and methods for improvement |
12/22/1994 | WO1994016085A3 Hybrid proteins having cross-linking and tissue-binding activities |
12/22/1994 | WO1994016075A3 Process for producing m-csf 223 |
12/22/1994 | WO1994016074A3 High molecular weight b-cell growth factor: interleukin-14 |
12/22/1994 | WO1994016071A3 Assays and genes for cell death |
12/22/1994 | DE4401419C1 Secretion of proteins of the outer membrane of Gram-negative bacteria by means of Gram-positive host organisms |
12/22/1994 | DE4225561A1 Measurement of forest damage using nucleic acid probes |
12/22/1994 | CA2166625A1 Methods and compositions for modulating lipid content of plant tissues |
12/22/1994 | CA2164953A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
12/22/1994 | CA2164946A1 High yielding influenza viruses |
12/22/1994 | CA2164864A1 Yeast promotor and use thereof |
12/22/1994 | CA2164811A1 Super proteins including interferons and interleukins |
12/22/1994 | CA2164732A1 Process for generating male sterile plants |
12/22/1994 | CA2164641A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
12/22/1994 | CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
12/22/1994 | CA2164623A1 Hybrid receptor molecules |
12/22/1994 | CA2164601A1 Herpes simplex virus type-2 protease |
12/22/1994 | CA2164518A1 Immunoreactive reagents employing monoamine oxidase |
12/22/1994 | CA2164510A1 Immunoassay reagents and methods for detecting brequinar and analogs |
12/22/1994 | CA2164298A1 Stress proteins and uses therefor |
12/22/1994 | CA2164297A1 Mengovirus as a vector for expression of foreign polypeptides |
12/22/1994 | CA2164295A1 Human-derived tumor cell growth inhibitors |
12/22/1994 | CA2164288A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
12/22/1994 | CA2164206A1 Oxidoreductase from filamentous fungi, dna coding therefor and cells transformed with said dna |
12/22/1994 | CA2164004A1 Method for generation of sequence sampled maps of complex genomes |
12/22/1994 | CA2163905A1 Inhibiting protein interactions |
12/22/1994 | CA2163665A1 Phytoremediation of metals |
12/22/1994 | CA2163523A1 Virus resistant plants |
12/22/1994 | CA2163345A1 Antibodies |
12/22/1994 | CA2163344A1 Humanised antibodies |
12/22/1994 | CA2162878A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
12/22/1994 | CA2162497A1 Adenoviral vectors for treatment of hemophilia |
12/22/1994 | CA2161811A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
12/22/1994 | CA2126294A1 Materials and methods for screening anti-osteoporosis agents |
12/22/1994 | CA2125761A1 Ubiquitin carrier enzyme e2-f1, purification, production and use |
12/21/1994 | EP0629706A2 Improved method for nucleic acid amplification |
12/21/1994 | EP0629700A2 Vector and mammalian cell line having improved productivity |
12/21/1994 | EP0629699A2 Promoter DNA fragment from coryneform bacteria |
12/21/1994 | EP0629698A1 DNA sequences conferring hypertransposability and vectors contructed therewith |
12/21/1994 | EP0629697A2 Materials and methods for screening anti-osteoporosis agents |
12/21/1994 | EP0629696A1 Recombinant DNA-derived bordetella toxin subunit analogs |
12/21/1994 | EP0629695A1 Novel Aminopeptidase from Streptomyces |
12/21/1994 | EP0629293A1 Assay for adrenal autoantigen |
12/21/1994 | EP0629244A1 Pathogen-targeted biocatalyst. |
12/21/1994 | EP0629243A1 Recombinant plant enzyme |
12/21/1994 | EP0629242A1 Method for enhancing plant precocity and/or reducing the stored nitrate content of a plant |
12/21/1994 | EP0629241A1 Self-incompatibility alleles of brassica |
12/21/1994 | EP0629240A1 Altered antibodies, products and processes relating thereto |
12/21/1994 | EP0629239A1 INSECTICIDAL TOXINS FROM THE PARASITIC WASP $i(BRACON HEBETOR) |
12/21/1994 | EP0629238A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
12/21/1994 | EP0629206A1 Immunological detection of organophosphates |
12/21/1994 | EP0629132A1 PURIFIED VACUOLATING TOXIN FROM $i(HELICOBACTER) PYLORI AND METHODS TO USE SAME |
12/21/1994 | EP0629131A1 ANTIGENS PROTECTIVE AGAINST $i(ECHINOCOCCUS GRANULOSUS) INFECTION AND VACCINES CONTAINING SUCH ANTIGENS |
12/21/1994 | EP0629130A1 Use of interleukin-10 to suppress graft-vs.-host disease |
12/21/1994 | EP0629129A1 Method for kidney tubulogenesis |
12/21/1994 | EP0624059A4 Combinatorial strategies for polymer synthesis. |
12/21/1994 | EP0551275B1 Non-a non-b sequences |
12/21/1994 | EP0494193B1 Diagnosis for malignant hyperthermia |
12/21/1994 | EP0220273B1 Synthetic antigens for the detection of aids-related disease |
12/21/1994 | EP0217814B2 A process for producing human growth hormone |
12/21/1994 | CN1096584A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of hla-c-clone 10/mage-1 derived peptides, and method for treating said......... |
12/21/1994 | CN1096541A Recombination of human macrophage colony stimulating factor by domestic silkworm gene engineering |
12/20/1994 | US5374618 Calcitonin peptides, and gene related pharmaceutical compositions |
12/20/1994 | US5374558 Recombinant DNA comprising promoter sequence in fowlpox virus genome transcribably linked to foreign gene |
12/20/1994 | US5374554 Microorganism and process for preparing D-biotin using the same |
12/20/1994 | US5374553 DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima |
12/20/1994 | US5374548 Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
12/20/1994 | US5374544 Mutated skeletal actin promoter |
12/20/1994 | US5374543 Enhanced indole biosynthesis |
12/20/1994 | US5374540 Chitinase-producing bacteria and plants |
12/20/1994 | US5374529 Methods of and compositions for diagnosis, monitoring and treating the early stages of osteoarthritis |
12/20/1994 | US5374527 High resolution DNA sequencing method using low viscosity medium |
12/20/1994 | US5374526 Digesting genomic DNA with restriction enzyme, detecting separated fragments with hybridizing probe to identify polymorphism in estrogen receptor gene, correlating with litter size |
12/20/1994 | US5374525 Methods to determine predisposition to hypertension and association of variant angiotensinogen gene and hypertension |
12/20/1994 | US5374522 Placing in sonic bath containing beads to distrupt cells and release cellular constituents |
12/20/1994 | US5374518 Monoclonal antibody for differentiating HIV-2 from HIM-1 seropositive individuals |
12/20/1994 | US5374431 Polypeptide chains having helical structure in aqueous environments containing crosslinkable surface adherable amino acids; form insoluble matrix for adhering cells |
12/14/1994 | EP0628820A2 Diagnosis and monitoring of colon cancer patients by measurement of NCA 50/90 in blood |